(Q51953047)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

title

Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

author name string

P Vermersch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

B Delisse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

S Lemaire

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

T Stojkovic

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

13 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

13 December 2019

page(s)

377-381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability

13 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Outcomes assessment in multiple sclerosis clinical trials: a critical analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

The quality-of-life effects of interferon beta-1b in multiple sclerosis. An extended Q-TWiST analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

International Quality of Life Assessment (IQOLA) Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Quality of life in multiple sclerosis in France, Germany, and the United Kingdom. Cost of Multiple Sclerosis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F1352458502MS826OA

10.1191/1352458502MS826OA

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12356203%20AND%20SRC:MED&resulttype=core&format=json

release_n5ruz7gybngxzeftmmivwgn6nu

13 December 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/n5ruz7gybngxzeftmmivwgn6nu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference